Syngo.Via
Payments companies reported to CMS as associated with Syngo.Via. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Syngo.Via, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Syngo.Via
These are the largest totals companies reported as associated with Syngo.Via. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Mcmenamy | Denver, CO | Diagnostic Radiology | $5,050.03 |
| Rahul Sheth | Houston, TX | Vascular & Interventional Radiology | $2,700.00 |
| Aalpen Patel | Danville, PA | Vascular & Interventional Radiology | $2,609.68 |
| Steven Huang | Houston, TX | Vascular & Interventional Radiology | $1,875.00 |
| Ketan Shah | Houston, TX | Vascular & Interventional Radiology | $1,750.00 |
| Milan Patel | Houston, TX | Vascular & Interventional Radiology | $1,750.00 |
| Peiman Habibollahi | Houston, TX | Vascular & Interventional Radiology | $1,750.00 |
| Paul Jabour | Clive, IA | Diagnostic Radiology | $632.94 |
| Elizabeth Morris | New York, NY | Diagnostic Radiology | $626.96 |
| Amol Shah | Sacramento, CA | Vascular & Interventional Radiology | $626.92 |
Prescribed Syngo.Via?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.